Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
HIV – Managing the Challenges By Dr D Spencer References: 1. South African National Department of Health (SANDOH). National Antenatal Sentinel HIV and Syphilis, Prevalence Survey in South Africa. 2011 2. Whiteside A. Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal. Keynote address delivered at the South African AIDS Conference, June 2013. 3. Fatti G, Bock P, Grimwood A, et al. Antiretroviral therapy outcomes in rural and urban children attending public health facilities in South Africa. 5th Conference on HIV Pathogenesis, Treatment and Prevention, IAS 2009, Cape Town. Poster presentation MOPEB077 4. Cleary SM, Birch S, Moshabela M, et al. Unequal access to ART: exploratory results from rural and urban case studies of ART use. Sex Transm Infect 2012; 88:141-146 5. Kinkel HF, Adelekan AM, Marcus TS, et al. Assessment of service quality of public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional study. BMC Health Serv Res 2012 Jul 31; 12(1): 228 [Epub ahead pf print] PMID: 22849727. 6. Macfarlane S, Racelis M, Muli-Musiime F. Public health in developing countries. Lancet 2000;356:841-46 7. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52: 793-800 8. Rundare A, et al. Comparison 2008 and 2010 South Africa National PMTCT Guidelines. 19th CROI, Seattle, WA. March 2012 (Abs 1003) 9. Fairall L, Bachmann MO, Lombard C, et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet 2012 (September 8); 380: 889-98 10. Brennan AT, Long L, Maskew M, et al. Outcomes of stable HIV-positive patients down-referred from a doctor-managed ART clinic to a nurse-managed primary health clinic for monitoring and treatment. AIDS 2011;25: 2027-2036 11. Long L, Brennan A, Fox MP, et al. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLOS Medicine 2011; 8: e1001055 12. Jani IL, Sitoe ER, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011; 378: 1572-79 13. Jong E, Sanne IM, van Rie A, et al. A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting. Public Health Action 2013; 3(1): S1-S5. Accessed on 17.05.2013 at http://dx.doi.org/10.5588/pha.12.0073. 14. Fatti G, Meintjes G, Shea J, et al. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicenter cohort study in South Africa. J Acquir Immune Defic Syndr 2012; 61(4):e50-8 15. Gardner LI, Marks G, Craw JA, et al for the Retention in Care Study Group. A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis 2012; 55(8): 1124-34 th 16. Egger M , et al. 14 CROI, Los Angeles, 2007. Abstract #62 17. Amuron B, Levin J, Birunghi J, et al. Mortality in an antiretroviral therapy programme in Jinja, South-East Uganda: a prospective cohort study. AIDS Research and Therapy 2011; 8: 39 18. Fregonese F, Collins IJ, Jourdain G, et al., for the HIV Prevention and Treatment Study Group. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Def Syndr 2-12; 60: 91-8 19. Pandie M, van der Plas, Maartens G, et al. The role of the Infectious Diseases Unit at Groote Schuur Hospital in addressing South Africa’s greatest burden of disease. SAMJ 2012; 102: 528-531 20. Johnson LF, Mossong J, Dorrington RE, et al for the International Epidemiologic Database to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. PLOS Medicine 2013 April; 10(4): 31001418 21. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011; 25: 2177-218 22. Fenner L, Brinkhof MWG, Keiser O, et al, for the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA). Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr 2010; 54(5); 524-32 23. Crepaz N, et al. AIDS 2006;20:143-57 24. Alkire S, Chen L. Global health and moral values. The Trinity Papers. Lancet 2004; 364: 1069-74 25. Marmot M, et al. Achieving health equity: from root causes to fair outcomes. Lancet 2007; 370: 2253-63 26. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48-57 27. Cohen MS, Chen YQ, McCauley M, et al for the HPTN 052 Study Group. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505 28. Le T, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013; 368: 218 29. May M, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343: d6016. (http:dx.doi.org/10.1136/bmj.d6016) 30. World Health Organization. Antiretroviral Treatment Guidelines, 2013. 31. Quinn T, et al. (2000). N Engl J Med;342:921-9 32. Kirk G, Galai V, Astemborski J, et al. Decline in community viral load strongly associated with declining HIV incidence among IDUs. Program of the 18th Conference on Retroviral and Opportunistic Infections (CROI), February 27March 2, 2011, Boston, Massachusetts. Abstract 484. 33. Charlebois ED, Das M, Porco TC, et al. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis 2011; 52: 1046-49 34. Palombi L, Bernava GM, Nucita A, et al. Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the drug resource enhancement against AIDS and Malnutrition model: antiretrovirals for reduction of populations infectivity, incidence and prevalence at the district level. Clin Infect Dis 2012; 55: 268-75 35. Carmona S, Macleod B, Cassim N, et al. A decline in community viral load in Cape Town and Johannesburg, South Africa between 2004 and 2011. Presentation at CROI, USA., February 2013. Abstract #1040a. 36. Estill J, Aubriere C, Egger M, et al, for IeDEA Southern Africa. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modeling analysis. AIDS 2012; 26: 14031413 37. Hoffman CJ, Charalambous S, Sim J, et al. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during firstline antiretroviral therapy in South Africa. Clin Infect Dis 2009; 49: 1928-35 38. Basson AE, Hoffman CJ, Charalambous S, et al. Viral re-suppression in the presence of HIV-1 drug resistance mutations. Oral presentation. Abstract. SA HIV Clinicians Society Conference, 25-28 November 2012, Cape Town, SA. 39. Long L, Fox M, Sanne I, et al. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS 2010;24: 915-919. 40. Gupta RK, Jordan MR, Sultan BJ, et al. Global trends in antiretroviral resistance in treatment-naïve individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and metaregression analysis. Lancet 2012; 380: 1250-58 41. Hamers RL, Sigaloff KCE, Wensing AM, et al. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (art) failure in 6 sub-Saharan countries: implications for second-Line ART strategies. Clin Infect Dis 2012; 54(11): 1660-9